313 results
ANCA Vasculitis - GPA, MPA, Eosinophilic GPA

doi:10.1038/s41572-020-0204-y

#ANCA #Vasculitis #GPA #MPA #Eosinophilic #rheumatology #diagnosis #comparison #table
ANCA Vasculitis - GPA ... , MPA, Eosinophilic ... GPA doi:10.1038 ... #MPA #Eosinophilic ... diagnosis #comparison #table
2021 ACR/VF Guidelines for Management of Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

#Granulomatosis #Polyangiitis #GPA
Polyangiitis (GPA ... Polyangiitis (MPA ... #Polyangiitis #GPA ... #Polyangiitis #MPA ... #rheumatology #algorithm
Rapidly Progressive Glomerulonephritis (RPGN)
RPGN has three primary pathophysiologic causes differentiated by immunofluorescence

Immune Complex Mediated (granular staining):
ANCA (C-ANCA): GPA ... >>> MPA > eGPA ... • MPO-ANCA (P-ANCA ... ): eGPA, MPA >>> ... differential #diagnosis #algorithm
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Polyangiitis (GPA ... Polyangiitis (MPA ... Vasculitis Management Algorithm ... #Polyangiitis #MPA ... ACR2021 #Guidelines #algorithm
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
Thiazide‐like diuretics, MRA ... Pharmacology #Comparison #Table ... #HalfLife #Dosing
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Polyangiitis (GPA ... Polyangiitis (MPA ... ACR2021 #Guidelines #algorithm
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
, Varenicline (tablet ... release (SR) (tablet ... Therapy #Comparison #Table ... #Agents #Dosing
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... #Pharmacology #Dosing ... #Dosing #Renal ... Impairment #CKD #Table
Mesenteric Ischemia - Differential Diagnostic Schema
Chronic: ASCVD, Venous, Vasculitides 5% (PAN, [E]GPA, IgA, MPA)
Acute
 - Venous
Vasculitides 5% (PAN, [E]GPA ... , IgA, MPA) Acute ... Differential #Diagnosis #algorithm
Stress Dose Steroids - Indications and Dosing

SUPPRESSED HPA AXIS:
 prednisone >20mg/day x 3 weeks or more
Indications and Dosing ... SUPPRESSED HPA ... #Indications #Dosing